Breaking News

Bio-Rad, Myriad RBM To Commercialize Biomarker Kits

New assays expand Bio-Rad’s current suite

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Bio‑Rad Laboratories and Myriad RBM, a wholly owned subsidiary of Myriad Genetics, have partnered to develop and distribute high-quality immunoassay kits. Myriad RBM has granted Bio-Rad exclusive distribution rights, for research purposes, to its catalog of quantitative multiplexed immunoassays currently available to run on Bio-Plex 200, Bio-Plex 3D, and Bio-Plex MAGPIX instruments.   Myriad RBM’s assays address needs for multiplex testing of samples with very low volumes when studying toxicolog...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters